表紙
市場調査レポート

等温核酸増幅技術(INAAT)の世界市場 - 用途(感染性疾患、血液検査、研究)、製品(計器、試薬)、最終利用者(病院、参照試験所ほか)別予測および分析

Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018

発行 MarketsandMarkets 商品コード 253613
出版日 ページ情報 英文 215 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
等温核酸増幅技術(INAAT)の世界市場 - 用途(感染性疾患、血液検査、研究)、製品(計器、試薬)、最終利用者(病院、参照試験所ほか)別予測および分析 Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018
出版日: 2014年05月16日 ページ情報: 英文 215 Pages
概要

等温核酸増幅技術(INAAT)市場は、従来のサーマルポリメラーゼ連鎖反応(PCR)に勝る先進等温条件分子検査への需要から、今後13.5%の複合年間成長率で拡大し、2018年には16億5100万ドルの規模に達する見込みです。

当レポートでは、等温核酸増幅技術の世界市場に注目し、今後の用途、製品、最終利用者、地域の別に取引規模の推移を予測するほか、市場発展への影響要因、技術開発、競合環境、有力企業などについての調査・分析情報をまとめています。

第1章 イントロダクション

  • 調査の目的
  • レポートの範囲
  • 調査方法
  • 一次・二次情報源から得られた重要データ

第2章 エグゼクティブサマリー

第3章 技術環境分析

  • 技術概要
  • 等温核酸増幅技術(INAAT)と従来方法を比較する - 競争優位性
  • 技術バリューチェーン分析
  • 技術上の能力と成熟度
  • 検査結果:一般的な核酸増幅検査とINAAT臨床現場即時検査を比較する
  • 各種INAATの比較分析

第4章 技術投資の将来性

  • 投資環境評価
    • 投資家ネットワーク
  • 技術評価:利害関係者間でのライセンス供与・取得の可能性
  • 機会戦略評価(OSE)グリッドによる技術投資に向けた有望応用分野分析
    • OSE - 評価パラメータ

第5章 市場環境分析

  • 市場セグメンテーション
  • 分子診断法(MDX)における市場構成比
    • 推進要因 - 解説
    • 抑制要因 - 解説
    • 課題 - 解説
  • 需要側分析

第6章 製品市場

  • 製品・技術の刷新 - 用途

第7章 用途市場

  • INAATおよび分子診断法
  • 感染性疾患診断
  • 血液検査
  • 実験室研究
  • がん研究
  • INAATの世界市場 - 用途別:2013-2018年
    • 感染性疾患市場 - 地域別
    • 血液検査市場 - 地域別
    • 研究市場 - 地域別

第8章 最終利用市場

  • 等温核酸増幅技術の世界市場 - 最終利用者別:2013-2018年
  • 世界市場 - 最終利用者別
    • 病院市場 - 地域別
    • 参照試験所市場 - 地域別
    • その他最終利用者市場 - 地域別
  • 病院向けINAAT市場 - 用途別
  • 参照試験所向けINAAT市場 - 用途別
  • その他最終利用者向けINAAT市場 - 用途別

第9章 地域分析

  • 技術導入・開発 - 重要所見
    • 等温核酸増幅技術の世界市場 - 地域別:2013-2018年
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • ハイテク導入地域

第10章 競合環境

  • 提携、協力、協定
  • 新製品開発
  • M&A

第11章 企業プロフィール

  • Alere
  • Becton, Dickinson and Company (Bd)
  • Biohelix
  • Biomerieux
  • 栄研化学株式会社
  • Hologic Gen-Probe
  • Lucigen
  • Meridian Bioscience, Inc.
  • New England Biolabs
  • Novartis Diagnostics
  • Nugen
  • Qiagen
  • Ustar Biotechnologies (Hangzhou) Ltd.

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2491

The isothermal nucleic acid amplification technology (INAAT) market is poised to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. Though PCR technology dominates the nucleic acid amplification technology market currently, adoption of INAAT technology is expected to be significant in coming years as it offers better clinical results in detecting pathogens during point-of-care testing.

Amongst different products, reagent segment is expected to grow at a faster growth due to its increasing demand in reliable, specific and faster detection of chronic diseases and genetic disorders. On the other hand, infectious disease was found to be the highest revenue generating application segment of isothermal nucleic acid amplification technology (INAAT) market in 2013; it is also expected to grow at higher CAGR of 14.4% during the forecast period due to increasing prevalence of various infectious diseases such as HIV and hepatitis A & B and increasing adoption of INAAT in advanced detection of pathogens globally. Amongst different end-users, adoption of INAAT technologies in reference laboratories is expected to be significant due to increasing importance of advanced technologies in different complex molecular testing.

North America commanded the largest market share of about 44% in 2013; whereas, Asian INAAT market is expected to witness the highest CAGR. High prevalence rate of infectious diseases and significant adoption of novel technologies are the major driving factors in the Asian INAAT market. Leading players in the global INAAT market are also expected to address the unmet needs in emerging nations such as India, China, South Africa, Singapore, and Middle East among others.

The grey area, while estimating the market size, includes the overlapping nature of the applications. The application segment included infectious diseases, blood screening, genetics, oncology, research. It was difficult to evaluate the appropriate applications of INAAT; these were later clarified with the help of various experts that participated during the study. Technology market is not estimated as these are proprietary technologies of leading companies. However, qualitative information such as technology evolution, value chain analysis, comparative analysis of various proprietary technologies, and technology roadmap are incorporated in the research study.

The notable players in the global isothermal nucleic acid amplification technology market include Alere, Inc. (U.S.), Becton, Dickinson & Company (U.S.), BioHelix (U.S.), bioMerieux (France), Hologic Gene-Probe (U.S.), and QIAGEN (The Netherlands).

The extensive market study covers a detailed coverage of market momentum, an in-depth analysis of various influencing factors as well as a comprehensive snapshot of competitive landscape. Such all-inclusive research would help market players to identify growth potential of different sub-segments and formulate a suitable strategy to enter various related industries with the best portfolio.

Table of Contents

1. Introduction

  • 1.1. Objectives Of The Study
  • 1.2. Report Scope
  • 1.3. Research Methodology
  • 1.4. Key Data From Secondary & Primary Sources

2. Executive Summary

3. Technology Landscape Analysis

  • 3.1. Technology Overview
  • 3.2. INAAT Vs. Conventional Methods - Competitive Advantages
  • 3.3. Technology Value Chain Analysis
  • 3.4. Technology Capability and Maturity
  • 3.5. Test Results General Nat Vs. INAAT Poct
  • 3.6. Comparative Analysis Of INAAT Types

4. Technology Investment Potential

  • 4.1. Investment Climate Assessment
    • 4.1.1. Investor Network
      • 4.1.1.1. Investment Climate Assessment
      • 4.1.1.2. Philanthropic Bodies
      • 4.1.1.3. Private Investors & Venture Capital Firms
      • 4.1.1.4. Insights on Current and Future Technology Investment Trends
      • 4.1.1.5. Some Of The Funds and Investments on INAAT
  • 4.2. Evaluation Of Technologies Available For Licensing & Acquisition For Stakeholders
  • 4.3. Analysis Of Potential Application Areas For Technology Investment Using Ose Grid
    • 4.3.1. Ose - Parameters For Evaluation

5. Market Landscape Analysis

  • 5.1. Market Segmentation
  • 5.2. Market Share in Molecular Diagnostics (Mdx)
  • 5.3. Market Dynamics
    • 5.3.1. Drivers - Description
    • 5.3.2. Restraints - Description
    • 5.3.3. Challenges - Description
  • 5.4. Demand-Side Analysis

6. Product Market

  • 6.1. Product/Technology Innovations - Applications
    • 6.1.1. Product/Technology Innovations - Applications
      • 6.1.1.1. INAAT Instrument Market - By Geography
      • 6.1.1.2. INAAT Reagent Market - By Geography

7. Applications Market

  • 7.1. INAAT & Molecular Diagnostics
  • 7.2. Infectious Disease Diagnostics
  • 7.3. Blood Screening
  • 7.4. Laboratory Research
  • 7.5. Cancer Research
  • 7.6. Global INAAT Market - By Application (2013-2018)
    • 7.6.1. INAAT Infectious Diseases Market, By Geography
    • 7.6.2. INAAT Blood Screening Market - By Geography
    • 7.6.3. INAAT Research Market - By Geography

8. End-User Market

  • 8.1. Global Isothermal Nucleic Acid Amplification Technology Market - By End User (2013-2018)
  • 8.2. Global Market - By End User
    • 8.2.1. INAAT Hospitals Market - By Geography
    • 8.2.2. INAAT Reference Laboratories Market - By Geography
    • 8.2.3. INAAT Other End-Users Market - By Geography
  • 8.3. INAAT Market For Hospitals, By Application
  • 8.4. INAAT Market For Reference Laboratories, By Application
  • 8.5. INAAT Market For Other End Users, By Application

9. Geographic Analysis

  • 9.1. Technology Adoption & Development - Key Findings
    • 9.1.1. Global Isothermal Nucleic Acid Amplification Technology Market - By Geography (2013-2018)
  • 9.2. North America
    • 9.2.1. North America - INAAT Market, By Application
    • 9.2.2. North America - Market, By Product
    • 9.2.3. North America - Market, By End User
  • 9.3. Europe
    • 9.3.1. Europe - INAAT Market, By Application
    • 9.3.2. Europe - Market, By Product
    • 9.3.3. Europe - Market, By End User
  • 9.4. Asia
    • 9.4.1. Asia - INAAT Market, By Application
    • 9.4.2. Asia - Market, By Product
    • 9.4.3. Asia - Market, By End User
  • 9.5. Rest Of The World (ROW)
    • 9.5.1. ROW- INAAT Market, By Application
    • 9.5.2. ROW- Market, By Product
    • 9.5.3. ROW- Market, By End User
  • 9.6. Regions With High Technology Adoption

10. Competitive Landscape

  • 10.1. Partnerships, Collaborations & Agreements
  • 10.2. New Product Launches
  • 10.3. Mergers and Acquisitions

11. Company Profiles

  • 11.1. Alere
  • 11.2. Becton, Dickinson and Company (Bd)
  • 11.3. Biohelix
  • 11.4. Biomerieux
  • 11.5. Eiken Chemical Co., Ltd.
  • 11.6. Hologic Gen-Probe
  • 11.7. Lucigen
  • 11.8. Meridian Bioscience, Inc.
  • 11.9. New England Biolabs
  • 11.10. Novartis Diagnostics
  • 11.11. Nugen
  • 11.12. Qiagen
  • 11.13. Ustar Biotechnologies (Hangzhou) Ltd.

List Of Tables

  • Table 1: NIH Funding Details and Estimation For Infectious Diseases During The Fiscal Year (Fy) 2010-2015
  • Table 2: Gates Foundation Grants ($) (2010-2014)
  • Table 3: Global Isothermal Nucleic Acid Amplification Technology Market, By Product, 2011-2018 ($Million)
  • Table 4: INAAT Instruments Market, By Geography, 2011-2018 ($Million)
  • Table 5: INAAT Reagents Market, By Geography, 2011-2018 ($Million)
  • Table 6: Global Isothermal Nucleic Acid Amplification Technology Market, By Application, 2011-2018 ($Million)
  • Table 7: INAAT Infectious Diseases Market, By Geography, 2011-2018 ($Million)
  • Table 8: INAAT Blood Screening Market, By Geography, 2011-2018 ($Million)
  • Table 9: INAAT Research Market, By Geography, 2011-2018 ($Million)
  • Table 10: Global Isothermal Nucleic Acid Amplification Technology Market, By End User, 2011-2018 ($Million)
  • Table 11: INAAT Hospitals Market, By Geography, 2011-2018 ($Million)
  • Table 12: INAAT Reference Laboratories Market, By Geography, 2011-2018 ($Million)
  • Table 13: INAAT Other End-Users Market, By Geography, 2011-2018 ($Million)
  • Table 14: INAAT Hospital Market Revenue, By Application, 2011-2018 ($Million)
  • Table 15: INAAT Reference Laboratories Market Revenue, By Application, 2011-2018 ($Million)
  • Table 16: INAAT Other End Users Market Revenue, By Application, 2011-2018 ($Million)
  • Table 17: North America: Market, By Application, 2011-2018 ($Million)
  • Table 18: North America: Market, By Product, 2011-2018 ($Million)
  • Table 19: North America: Market, By End User, 2011-2018 ($Million)
  • Table 20: Europe: Market, By Application, 2011-2018 ($Million)
  • Table 21: Europe: Market, By Product, 2011-2018 ($Million)
  • Table 22: Europe: Market, By End User, 2011-2018 ($Million)
  • Table 23: Asia: Market, By Application, 2011-2018 ($Million)
  • Table 24: Asia: Market, By Product, 2011-2018 ($Million)
  • Table 25: Asia: Market, By End User, 2011-2018 ($Million)
  • Table 26: ROW: Market, By Application, 2011-2018 ($Million)
  • Table 27: ROW: Market, By Product, 2011-2018 ($Million)
  • Table 28: ROW: Market, By End User, 2011-2018 ($Million)
  • Table 29: Partnerships, Collaborations & Agreements, 2011-2014
  • Table 30: New Product Launches, 2011-2014
  • Table 31: Mergers & Acquisitions, 2011-2014

List Of Figures

  • Figure 1: Research Methodology
  • Figure 2: INAAT Vs. Molecular Diagnostics: Market Revenue Forecast, 2011-2018
  • Figure 3: Technology Evolution
  • Figure 4: INAAT Vs. Conventional Methods - Competitive Advantages
  • Figure 5: Technology Value Chain Analysis
  • Figure 6: INAAT Capability Towards Poct
  • Figure 7: Test Results General Nat Vs. INAAT Poct
  • Figure 8: Comparative Analysis Of INAAT Types
  • Figure 9: Technology Roadmap
  • Figure 10: Attractive Forces For Increased Market Value
  • Figure 11: Investor Network
  • Figure 12: NIH Funds Towards Infectious Diseases
  • Figure 13: Opportunity Strategic Evaluation Analysis
  • Figure 14: Market Segmentation
  • Figure 15: Market Share in Molecular Diagnostics (Mdx)
  • Figure 16: Market Dynamics
  • Figure 17: Drivers Impact - Timeline
  • Figure 18: Restraints Impact - Timeline
  • Figure 19: Current and Emerging Opportunities
  • Figure 20: Demand-Side Analysis
  • Figure 21: Market Share, By Product, 2013-2018
  • Figure 22: Global Market, By Product, 2013 & 2018 ($Million)
  • Figure 23: INAAT Instruments Market, By Geography, 2013 & 2018 ($Million)
  • Figure 24: Global INAAT Reagents Market, By Geography, 2013 & 2018 ($Million)
  • Figure 25: Isothermal Nucleic Acid Amplification Technology Applications Market
  • Figure 26: INAAT Products Currently Available For Infectious Diseases
  • Figure 27: Market Share, By Application, 2013-2018
  • Figure 28: Global Market, By Application, 2013 & 2018 ($Million)
  • Figure 29: INAAT Infectious Diseases Market, By Geography, 2013 & 2018 ($Million)
  • Figure 30: INAAT Blood Screening Market, By Geography, 2013 & 2018 ($Million)
  • Figure 31: INAAT Research Market, By Geography, 2013 & 2018 ($Million)
  • Figure 32: Market Share, By End User, 2013-2018
  • Figure 33: Global Market, By End-User, 2013 & 2018 ($Million)
  • Figure 34: INAAT Hospitals Market, By Geography, 2013 & 2018 ($Million)
  • Figure 35: INAAT Reference Laboratories Market, By Geography, 2013 & 2018 ($Million)
  • Figure 36: INAAT Other End-Users Market, By Geography, 2013 & 2018 ($Million)
  • Figure 37: INAAT Hospital Market Revenue, By Application, 2013 Vs. 2018, ($Million)
  • Figure 38: INAAT Reference Laboratories Market Revenue, By Application, 2013 Vs 2018 ($Million)
  • Figure 39: INAAT Others End Users Market Revenue, By Application, 2013 Vs. 2018 ($Million)
  • Figure 40: Market Share, By Geography, 2013-2018
  • Figure 41: North America: Market, By Application, 2013 Vs. 2018 ($Million)
  • Figure 42: North America: Market, By Product, 2013 Vs.2018 ($Million)
  • Figure 43: North America: Market, By End User, 2013 Vs. 2018 ($Million)
  • Figure 44: Europe: Market, By Application, 2013 Vs.2018 ($Million)
  • Figure 45: Europe: Market, By Product, 2013 Vs.2018 ($Million)
  • Figure 46: Europe: Market, By End User, 2013 Vs.2018 ($Million)
  • Figure 47: Asia: Market, By Application, 2013 Vs.2018 ($Million)
  • Figure 48: Asia: Market, By Product, 2013 Vs.2018 ($Million)
  • Figure 49: Asia: Market, By End User, 2013 Vs.2018 ($Million)
  • Figure 50: ROW: Market, By Application, 2013 Vs.2018 ($Million)
  • Figure 51: ROW: Market, By Product, 2013 Vs.2018 ($Million)
  • Figure 52: ROW: Market, By End User, 2013 Vs.2018 ($Million)
  • Figure 53: Key Growth Strategies Of The Global Isothermal Nucleic Acid Amplification Technologies Market, 2011-2014
Back to Top